Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kay Brune

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
ALTEX|April 4, 2003
[Self experimentation and in vitro research will not suffice: a plea for more refinement]Kay Brune
ALTEX|August 8, 2002
Animal experimentation in sciences: sadistic nonsense or indispensable necessity?Kay Brune
ALTEX|March 30, 2004
Replacement and refinement of animal experimentation in drug research has been and will be a permanent and necessary processKay Brune
Pharmacoepidemiology and Drug Safety|March 6, 2014
Diclofenac: increase of myocardial infarctions at low doses?Kay Brune
Swiss Medical Weekly|April 23, 2005
COX-2 selective inhibitors--they are still the best treatment for many patients!Kay Brune
American Journal of Therapeutics|April 10, 2002
Next generation of everyday analgesicsKay Brune
Current Medical Research and Opinion|October 24, 2007
Persistence of NSAIDs at effect sites and rapid disappearance from side-effect compartments contributes to tolerabilityKay Brune
MMW Fortschritte Der Medizin|July 3, 2016
[Not Available]Kay Brune
Medizinische Monatsschrift Fur Pharmazeuten|February 8, 2005
[Treatment of musculoskeletal pain]Kay Brune
MMW Fortschritte Der Medizin|September 9, 2004
[New evaluation by the EU approval committee. Benefits of cox-2 inhibitors outweigh possible risks (interview by Dr. Thomas Meissner)]Kay Brune
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
ALTEX|April 4, 2003
[Self experimentation and in vitro research will not suffice: a plea for more refinement]Kay Brune
ALTEX|August 8, 2002
Animal experimentation in sciences: sadistic nonsense or indispensable necessity?Kay Brune
ALTEX|March 30, 2004
Replacement and refinement of animal experimentation in drug research has been and will be a permanent and necessary processKay Brune
Pharmacoepidemiology and Drug Safety|March 6, 2014
Diclofenac: increase of myocardial infarctions at low doses?Kay Brune
Swiss Medical Weekly|April 23, 2005
COX-2 selective inhibitors--they are still the best treatment for many patients!Kay Brune
American Journal of Therapeutics|April 10, 2002
Next generation of everyday analgesicsKay Brune
Current Medical Research and Opinion|October 24, 2007
Persistence of NSAIDs at effect sites and rapid disappearance from side-effect compartments contributes to tolerabilityKay Brune
MMW Fortschritte Der Medizin|July 3, 2016
[Not Available]Kay Brune
Medizinische Monatsschrift Fur Pharmazeuten|February 8, 2005
[Treatment of musculoskeletal pain]Kay Brune
MMW Fortschritte Der Medizin|September 9, 2004
[New evaluation by the EU approval committee. Benefits of cox-2 inhibitors outweigh possible risks (interview by Dr. Thomas Meissner)]Kay Brune
Pageof 11